Thursday, September 1, 2016

How to manage ad partners in regulated industries: Pharma (part 5 of 5)

In the last of her five-part series, contributor Lori Weiman takes a deep dive into FDA guidelines and explains how pharmaceutical advertisers and their partners can avoid costly violations.


No comments:

Post a Comment